Optiscan Imaging opened its new US regional office in Rochester, Minnesota, appointing Ken Lock as head of clinical affairs and Nicole Williams as head of regulatory affairs.

The move coincides with Optiscan's expansion in the US, aiming to strengthen its clinical device portfolio and Food and Drug Administration regulatory submissions.

Lock and Williams bring extensive experience in global clinical trials and FDA negotiations.

Optiscan's expansion into the US market and its presence in the Minnesota BioBusiness Center are expected to facilitate FDA approval for its medical imaging technologies.